Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4752621
Max Phase: Preclinical
Molecular Formula: C19H16N2O3S
Molecular Weight: 352.42
Molecule Type: Unknown
Associated Items:
ID: ALA4752621
Max Phase: Preclinical
Molecular Formula: C19H16N2O3S
Molecular Weight: 352.42
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(N2C(=O)CSC2c2ccc3cccc(O)c3n2)cc1
Standard InChI: InChI=1S/C19H16N2O3S/c1-24-14-8-6-13(7-9-14)21-17(23)11-25-19(21)15-10-5-12-3-2-4-16(22)18(12)20-15/h2-10,19,22H,11H2,1H3
Standard InChI Key: MTQUXKDZDDTRIK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 352.42 | Molecular Weight (Monoisotopic): 352.0882 | AlogP: 3.73 | #Rotatable Bonds: 3 |
Polar Surface Area: 62.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 3.11 | CX LogD: 3.10 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.78 | Np Likeness Score: -0.66 |
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |
Source(1):